Cara Therapeutics (CARA) PT Lowered to $25 at Piper Sandler
Tweet
Share
E-mailGet Alerts CARA Hot Sheet
Price: $0.67 -5.63%
Rating Summary:
10 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 2
Rating Summary:
10 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 2
Join SI Premium – FREE
Piper Sandler analyst David Amsellem lowered the price target on Cara Therapeutics (NASDAQ: CARA) to $25.00 (from $30.00) while maintaining a rating.
You May Also Be Interested In
- BofA Securities Upgrades Bharat Forge Ltd. (BHFC:IN) to Buy
- Skandinaviska Enskilda Banken AB (SEBA:SS) (SKVKY) PT Raised to SEK126 at Barclays
- Deutsche Boerse AG (DB1:GR) (DBOEY) PT Lowered to EUR193 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
